Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.
2.

Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections.

Langereis JD, van der Flier M, de Jonge MI.

Front Immunol. 2018 Aug 23;9:1925. doi: 10.3389/fimmu.2018.01925. eCollection 2018. Review.

3.

Desialylation of Platelets by Pneumococcal Neuraminidase A Induces ADP-Dependent Platelet Hyperreactivity.

Kullaya V, de Jonge MI, Langereis JD, van der Gaast-de Jongh CE, Büll C, Adema GJ, Lefeber D, Cremers AJ, Mmbaga BT, de Groot PG, de Mast Q, van der Ven AJ.

Infect Immun. 2018 Sep 21;86(10). pii: e00213-18. doi: 10.1128/IAI.00213-18. Print 2018 Oct.

PMID:
30037798
4.

Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation.

Kiers D, Wielockx B, Peters E, van Eijk LT, Gerretsen J, John A, Janssen E, Groeneveld R, Peters M, Damen L, Meneses AM, Krüger A, Langereis JD, Zomer AL, Blackburn MR, Joosten LA, Netea MG, Riksen NP, van der Hoeven JG, Scheffer GJ, Eltzschig HK, Pickkers P, Kox M.

EBioMedicine. 2018 Jul;33:144-156. doi: 10.1016/j.ebiom.2018.06.021. Epub 2018 Jul 4.

5.

Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance.

Heise T, Langereis JD, Rossing E, de Jonge MI, Adema GJ, Büll C, Boltje TJ.

Cell Chem Biol. 2018 Oct 18;25(10):1279-1285.e8. doi: 10.1016/j.chembiol.2018.05.018. Epub 2018 Jul 5.

PMID:
29983272
6.

The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites.

Behet MC, Kurtovic L, van Gemert GJ, Haukes CM, Siebelink-Stoter R, Graumans W, van de Vegte-Bolmer MG, Scholzen A, Langereis JD, Diavatopoulos DA, Beeson JG, Sauerwein RW.

Infect Immun. 2018 May 7. pii: IAI.00920-17. doi: 10.1128/IAI.00920-17. [Epub ahead of print]

7.

Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

van der Maten E, van den Broek B, de Jonge MI, Rensen KJW, Eleveld MJ, Zomer AL, Cremers AJH, Ferwerda G, de Groot R, Langereis JD, van der Flier M.

Infect Immun. 2018 Mar 22;86(4). pii: e00010-18. doi: 10.1128/IAI.00010-18. Print 2018 Apr.

8.

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.

Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, van der Flier M.

J Clin Immunol. 2018 Feb;38(2):185-192. doi: 10.1007/s10875-017-0474-7. Epub 2018 Jan 15.

9.

Spleen-derived IFN-γ induces generation of PD-L1+-suppressive neutrophils during endotoxemia.

Langereis JD, Pickkers P, de Kleijn S, Gerretsen J, de Jonge MI, Kox M.

J Leukoc Biol. 2017 Dec;102(6):1401-1409. doi: 10.1189/jlb.3A0217-051RR. Epub 2017 Oct 3.

PMID:
28974543
10.

Genetic background impacts vaccine-induced reduction of pneumococcal colonization.

Kuipers K, van Selm S, van Opzeeland F, Langereis JD, Verhagen LM, Diavatopoulos DA, de Jonge MI.

Vaccine. 2017 Sep 18;35(39):5235-5241. doi: 10.1016/j.vaccine.2017.08.023. Epub 2017 Aug 17.

11.

Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.

Kuipers K, Jong WSP, van der Gaast-de Jongh CE, Houben D, van Opzeeland F, Simonetti E, van Selm S, de Groot R, Koenders MI, Azarian T, Pupo E, van der Ley P, Langereis JD, Zomer A, Luirink J, de Jonge MI.

Infect Immun. 2017 Sep 20;85(10). pii: e00281-17. doi: 10.1128/IAI.00281-17. Print 2017 Oct.

12.

Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction.

Heise T, Büll C, Beurskens DM, Rossing E, de Jonge MI, Adema GJ, Boltje TJ, Langereis JD.

Bioconjug Chem. 2017 Jul 19;28(7):1811-1815. doi: 10.1021/acs.bioconjchem.7b00224. Epub 2017 Jun 27.

13.

Non-encapsulated Streptococcus pneumoniae, vaccination as a measure to interfere with horizontal gene transfer.

Langereis JD, de Jonge MI.

Virulence. 2017 Aug 18;8(6):637-639. doi: 10.1080/21505594.2017.1309492. Epub 2017 Mar 22. No abstract available.

14.

A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.

van der Maten E, de Jonge MI, de Groot R, van der Flier M, Langereis JD.

Sci Rep. 2017 Feb 8;7:42137. doi: 10.1038/srep42137.

15.

Bacterial Lysis through Interference with Peptidoglycan Synthesis Increases Biofilm Formation by Nontypeable Haemophilus influenzae.

Marti S, Puig C, Merlos A, Viñas M, de Jonge MI, Liñares J, Ardanuy C, Langereis JD.

mSphere. 2017 Jan 18;2(1). pii: e00329-16. doi: 10.1128/mSphere.00329-16. eCollection 2017 Jan-Feb.

16.

Alternative pathway regulation by factor H modulates Streptococcus pneumoniae induced proinflammatory cytokine responses by decreasing C5a receptor crosstalk.

van der Maten E, de Bont CM, de Groot R, de Jonge MI, Langereis JD, van der Flier M.

Cytokine. 2016 Dec;88:281-286. doi: 10.1016/j.cyto.2016.09.025. Epub 2016 Oct 6.

17.

Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.

van der Maten E, van Selm S, Langereis JD, Bootsma HJ, van Opzeeland FJ, de Groot R, de Jonge MI, van der Flier M.

PLoS One. 2016 Feb 12;11(2):e0149307. doi: 10.1371/journal.pone.0149307. eCollection 2016.

18.

Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease.

van der Maten E, Westra D, van Selm S, Langereis JD, Bootsma HJ, van Opzeeland FJ, de Groot R, Ruseva MM, Pickering MC, van den Heuvel LP, van de Kar NC, de Jonge MI, van der Flier M.

J Infect Dis. 2016 Jun 1;213(11):1820-7. doi: 10.1093/infdis/jiw029. Epub 2016 Jan 21.

19.

Invasive Disease Caused by Nontypeable Haemophilus influenzae.

Langereis JD, de Jonge MI.

Emerg Infect Dis. 2015 Oct;21(10):1711-8. doi: 10.3201/eid2110.150004. No abstract available.

20.

From microbial gene essentiality to novel antimicrobial drug targets.

Mobegi FM, van Hijum SA, Burghout P, Bootsma HJ, de Vries SP, van der Gaast-de Jongh CE, Simonetti E, Langereis JD, Hermans PW, de Jonge MI, Zomer A.

BMC Genomics. 2014 Nov 5;15:958. doi: 10.1186/1471-2164-15-958.

Supplemental Content

Loading ...
Support Center